Daily Health Pharmacy

Category: Medicines - Page 4

Roger Donoghue 14 January 2026 15
Cardiovascular Generics: What Safety Studies and Real-World Data Really Show

Cardiovascular Generics: What Safety Studies and Real-World Data Really Show

Cardiovascular generics save billions but raise safety questions. Real-world data shows they work for most people, but small risks exist - especially after switching. Here’s what the studies really say.

View More
Roger Donoghue 13 January 2026 13
Hiccups Triggered by Medications: Common Causes and Effective Remedies

Hiccups Triggered by Medications: Common Causes and Effective Remedies

Hiccups from medications like dexamethasone, opioids, and benzodiazepines are more common than you think. Learn the top causes, proven remedies, and what to do when home tricks don’t work.

View More
Roger Donoghue 12 January 2026 9
Quality concerns: when clinicians question generic manufacturing

Quality concerns: when clinicians question generic manufacturing

Clinicians are raising alarms about rising quality issues in generic drugs, especially those made overseas. Studies show higher rates of severe adverse events with Indian-made generics, and outdated manufacturing practices are causing dangerous shortages. Transparency and domestic production may be key to fixing the system.

View More
Roger Donoghue 11 January 2026 11
Pain Management Combinations: Available Generic Fixed-Dose Products

Pain Management Combinations: Available Generic Fixed-Dose Products

Generic fixed-dose pain combinations like tramadol/acetaminophen and ibuprofen/acetaminophen offer stronger relief than single drugs for acute pain. Learn which combos are available, how they work, their risks, and how to use them safely.

View More
Roger Donoghue 9 January 2026 13
Future of Generic Combinations: Regulatory and Market Trends

Future of Generic Combinations: Regulatory and Market Trends

Generic combinations are transforming the pharmaceutical industry by combining multiple drugs into smarter, more effective formulations. Learn how regulatory shifts and market demand are driving growth in super generics, from inhalers to extended-release pills.

View More
Roger Donoghue 2 January 2026 10
Therapeutic Equivalence: Are Authorized Generics Really the Same as Brand Drugs?

Therapeutic Equivalence: Are Authorized Generics Really the Same as Brand Drugs?

Authorized generics are identical to brand-name drugs in every way-same ingredients, same factory, same quality. Learn how they compare, why they matter, and when to ask for them.

View More
Roger Donoghue 1 January 2026 12
Insurance Coverage of Biosimilars: How Prior Authorization and Tier Placement Block Affordable Access

Insurance Coverage of Biosimilars: How Prior Authorization and Tier Placement Block Affordable Access

Biosimilars offer major cost savings over brand-name biologics, but insurance plans often block access through prior authorization and identical tier placement. Learn how formulary rules and PBM practices limit adoption-and what’s changing in 2025.

View More
Roger Donoghue 29 December 2025 13
How to Report Adverse Drug Reactions to FDA MedWatch

How to Report Adverse Drug Reactions to FDA MedWatch

Learn how to report adverse drug reactions to the FDA's MedWatch system. Understand what counts as serious, how to file a report, and why your input matters-even if you never hear back.

View More
Roger Donoghue 27 December 2025 11
How Medicines Work and When They're Safe to Use

How Medicines Work and When They're Safe to Use

Learn how medicines work at a molecular level and what makes them safe-or dangerous-to use. Understand mechanisms of action, drug interactions, and how knowledge prevents harmful side effects.

View More
Roger Donoghue 25 December 2025 7
Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

Big Pharma uses legal loopholes like product hopping and REMS abuse to block generic substitution, keeping drug prices high. Courts and the FTC are fighting back, but patients still pay the price.

View More